Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Skanska invests EUR 45 M, about SEK 450 M, in the second phase of the Equilibrium office project in Bucharest, Romania

Skanska invests EUR 45M, about SEK 450 M, in the second phase of the Equilibrium office project in Bucharest, Romania. The second building will have a total leasable area of 19,900 square meters.The 12-storey building will be built in the northern part of Bucharest. More than 200 parking lots above- and underground will also be built. The project is LEED Gold pre-certified. Construction works are planned to start in February 2020 and is scheduled for completion in the first quarter of 2023.  At its completion, the entire two-building Equilibrium complex will offer 40,800 square meters

Musti Group plc Interim Report 1 October 2020 – 31 December 2020

Musti Group plc Interim Report              9 February 2021 at 8:30 a.m. EET Musti Group plc Interim Report 1 October 2020 – 31 December 2020 Strongest quarter so far October 2020 – December 2020 · Group net sales totalled EUR 84.3 million (70.3 million), an increase of 19.9%. · Like-for-like sales growth was 13.1%. · Adjusted EBITA was EUR 10.6 (7.8) million, up by 36.4%. · Adjusted EBITA margin was 12.6% (11.1%). · Operating profit increased by 56.3% to EUR 8.4 (5.4) million, representing 10.0% (7.7%) of net revenue. · Profit for the period totalled EUR 7.8 (3.

Resurs Bank Year-end Report January–December 2020

“Ambitious agenda for 2021 and several new partners” Nils Carlsson, CEO Resurs Bank AB1 July—31 December 2020* · Lending to the public fell 2% to SEK 30,858 million, up 2% in constant currencies. · As previously communicated, the half-year included nonrecurring costs of SEK 70 million related to the transformation journey. · Operating income fell 6% to SEK 1,658 million. · C/I before credit losses was 42.2% (38.1), excluding nonrecurring costs to 38.4%. · Operating profit before credit losses fell 13% to SEK 958 million, excluding nonrecurring costs the decline was 5%. ·

Full year report January-December 2020

Viaplay hits target of 3m subscribers with 33% YoY growth and 207k new subscribers in Q4· Viaplay paying subscribers up 207k QoQ and up 33% (749k) YoY to 3,020k to meet year-end 3m target. Expected addition of 650k new paying subscribers in 2021 · 6% organic sales growth and reported sales of SEK 3,182m (3,825m including SEK 724m contribution from subsequently deconsolidated Viasat Consumer business) · 22% increase in operating income before associated company income (ACI) and items affecting comparability (IAC) when excluding Q4 2019 SEK 111m contribution from Viasat Consumer

Herantis Pharma and Nanoform Enter into Agreement for Proof of Concept Collaboration

Press Release Herantis Pharma Plc 9[th] February 2021 at 08:10 a.m. EET Herantis Pharma Plc (“Herantis”), an innovative clinical stage biotech company pioneering new disease modifying and regenerative biologic and gene therapies, today announced that they have entered into a Biologics Proof of Concept Agreement with Nanoform Finland Plc, an innovative nanoparticle medicine enabling company.  The collaboration provides for formulation Proof of Concept studies (PoCs) to combine Herantis’ intranasally administered CDNF therapy for Parkinson’s disease, with Nanoform nanoparticle

Nanoform and Herantis sign Biologics Proof of Concept Agreement

Press release Nanoform Finland Plc February 9[th], 2021 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform and Herantis sign Biologics Proof of Concept Agreement Helsinki, Finland – Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc, an innovative clinical stage biotech company, today announced that they have signed a Biologics Proof of Concept Agreement for formulation Proof of Concept projects (PoCs) aiming to enhance nasal drug delivery to the brain of Herantis’ CDNF therapies for Parkinson’s disease using Nanoform’s

Amish Mody joins Veriff as the Chief Financial Officer

Amish Mody joins the leading global identity verification (IDV) provider Veriff as their new Chief Financial Officer. Mody has a solid track record in the financial sector, having previously served as VP of Finance at the UK-based fintech Monese and also as an investment banker.“I am really excited to join Veriff, especially because I see a huge growth potential for the whole identity verification industry as the global digitalisation has accelerated over the last year. So far I’ve experienced the ID verification business from a client's perspective, and now I’ll get to see the other side,”

Fazer supports the training of Finnish farmers to increase regenerative carbon farming

Fazer contributes to the training of Finnish farmers to increase carbon sequestration through regenerative farming. The aim is to make farming more sustainable by promoting the transformation of Finnish farmland from sources of carbon into carbon sinks. The training for farmers will be provided as a free online course developed in cooperation by the Baltic Sea Action Group (BSAG) and its stakeholder network and the software company Reaktor.As a significant user of grains, Fazer bears its responsibility for developing sustainable farming and has promoted sustainable farming practices for

Atea Q4 2020 financial report and presentation

Atea, the leading provider of IT infrastructure products and services in the Nordic and Baltic regions, reports very strong revenue and profit growth in the fourth quarter, driving record high financial results for the full year 2020. Strong revenue and profit growthAtea’s revenue in Q4 2020 was NOK 11,676 million, an increase of 14.4% from last year, with growth across all lines of business. EBIT increased by 27.1% to NOK 387 million, with increased operating profit across all countries. For the full year 2020, Atea reported record high revenue of NOK 39.5 billion, up 7.8% from

SOTIO has stopped collaboration trial with the dendritic cell vaccine DCVAC in combination with ONCOS-102

Oslo, Norway, 9 February 2021 – Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that collaboration partner SOTIO has stopped the combination trial assessing the combination of ONCOS-102 and DCVAC/PCa in prostate cancer. Only a very limited patient population fulfilled the strict inclusion criteria. Therefore, the recruitment could not meet originally planned numbers.The phase I trial prostate cancer study was paid for and run by the Czech biotech company SOTIO, investigating whether ONCOS-

OXE Marine AB (publ) appoints Magnus Grönborg as CEO and Myron Mahendra as EVP Business Development , Sales and Marketing

The board of directors of OXE Marine AB (publ) (the “Company”) has resolved to appoint Magnus Grönborg as CEO and to reorganize its management team by appointing the current CEO Myron Mahendra as EVP Business Development, Sales and Marketing. In addition, the chairman of the board Anders Berg will increase his operational focus on the company by assuming a supportive operational role with the management team. Magnus Grönborg will replace Myron Mahendra as CEO in a few months, with the closer date yet to be agreed.OXE Marine AB (publ) (NASDAQ STO: OXE, OTCQX: CMMCF) is moving into the next

Enviro and Michelin sign definitive agreements on strategic partnership

Scandinavian Enviro Systems (publ) (“Enviro” or “The Company”) and the French global tyre manufacturer Michelin have today signed three definitive agreements that form the basis of the companies’ strategic partnership. The agreements regulate the terms for a jointly owned plant for the recycling of end-of-life tyres in Chile, the terms and conditions for Michelin’s use of Enviro’s patented technology, and payment for this, and the terms and conditions for payment to Enviro for deliveries of technology and services to the jointly owned plant in Chile.Before the agreements can enter into

Q-Free: Conversion of convertible bonds

Reference is made to the stock exchange notice 13 January 2021 regarding issuance and registration of new shares following conversion of Q-Free ASA's NOK 80 million unsecured subordinated convertible bond loan (the "Convertible Bond Loan"), for an aggregate principal amount of NOK 69,000,000. Q-Free ASA has now received additional conversion notices from the paying and conversion agent for the Convertible Bond Loan for bonds representing an additional amount of NOK 8,000,000. This will be converted into 2,202,096 new shares at the conversion price of NOK 3.6329. The aggregated received

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this stock exchange announcement or the acceptance of any tender of shares would contravene applicable laws or regulations. (Oslo, 8 February 2021): Reference is made to the mandatory offer (the “Offer”) from Rieber & Søn AS (the “Offeror”) to acquire all shares in Q-Free ASA (“Q-Free” or the “Company”) pursuant to an offer document

YEAR-END REPORT 2020

2020 FISCAL YEAR · Rental revenue increased 12% to SEK 2,898 M (SEK 2,581 M for the preceding year). · Profit from property management increased 19% to SEK 2,389 M (2,001). · Profit from property management per Class A and B share after dilution rose 20% to SEK 6.62 (5.51). · In total, property revaluation affected profit by SEK 2,003 M (1,956). · Revaluation of financial instruments had an impact of SEK 210 M (884). · Profit after tax for the year was SEK 3,711 M (4,111). · Cash flow from operating activities before changes in working capital rose 24% to SEK 2,219 M (

#21-50 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-49 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Kurppa Hosk breathe new life into Berghs SoC visual identity

The current visual identity was created by the advertising and design legend Lars Hall in the end of the 1990s. The identity was then created in order to strengthen Berghs’ business profile and to broaden the school’s focus on communications, rather than purely advertising and design. The current update to the classic identity will allow for new digital opportunities and greater design dynamics. - Kurppa Hosk was selected as they understood the necessity of updating Berghs’ visual identity while honoring the classic identity. Kurppa Hosk has handled this balance sensitively, crafting a

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 8 February 2021 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck. +--+-----------------+----------+---------+|1.|Details of the || |person || |discharging || |managerial || |responsibilities || |/ person closely || |associated |+--+-----------------+---

Herantis Pharma to Participate in the Upcoming Swiss Nordic Bio Conference

Press Release Herantis Pharma Plc  8 February 2021 at 05:20 p.m. EET   Herantis Pharma Plc (“Herantis”), an innovative clinical stage biotech company pioneering new disease modifying and regenerative biologic and gene therapies, today announced that Craig Cook, Chief Executive Officer, will hold a company presentation in the upcoming Swiss Nordic Bio Conference investor conference, this year taking place virtually. Event Details: Swiss Nordic Bio Conference 10 – 11 February 2021 On 11 February 2021 all presentations will be available via a digital library, which is

Aptahem receives patent approval in India for patent family 1

Aptahem AB (publ) announce today that the company has received patent approval in India for patent family 1, with patent application number 6250/DELNP/2010. The patent, with the patent number 353024, covers the protection of the company’s aptamer structures.The patent approval grants the company protection for Apta-1, Apta-2 and Apta-3 in India until 2029. Similar patents have previously been approved in Europe, USA, Canada and China. CEO Mikael Lindstam comments: “We are delighted to announce that we now have received patent approval in the last country, India, for our patent

ABS Awards World’s First Notation Recognizing Infectious Disease Mitigation to Tasik Subsea’s Southern Star

Vessel Meets Industry-Leading ABS Requirements(SINGAPORE) Tasik Subsea’s Diving Support Vessel Southern Star has become the first ever to be awarded an ABS Infectious Disease Mitigation notation. The ABS-classed vessel has met the requirements outlined in the ABS Guide for Mitigation of Infectious Disease Transmission On Board Marine and Offshore Assets, which was developed from a range of independent governmental and commercial guidance, including the United States Centers for Disease Control and Prevention and published in November 2020. The IDM-A (Infectious Disease Mitigation-

Correction regarding ISIN code for the share in the prospectus

In the prospectus published earlier today regarding OncoZenge AB’s (publ) rights issue and listing on Nasdaq First North Growth Market, it has been noted that the ISIN code for the share is incorrect. The correct ISIN code for the share is SE0015504097.THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES

Raisio has agreed to sell EUR 2.8 million receivable and will record it in other operating income in the first quarter of 2021

Raisio plc, Stock Exchange Release on February 8, 2021 In a stock exchange release published on December 17, 2020, Raisio announced a positive arbitration award in connection with the partial suspension of Raisioaqua's business in 2018. Due to the uncertainty related to the receivable, Raisio did not record the amount to be reimbursed in full or in part in its income statement. Raisio entered into an agreement for the sale of the receivable and records EUR 2.8 million in other operating income in 2021. RAISIO PLCBoard of Directors Further information:Toni Rannikko, CFO, tel.

There are no items matching the current filter
There are no more items matching the current filter
Back to top